lobbying_activities: 3427215

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3427215	43b23449-47cd-45df-8578-b97b69c3d3f5	Q3	GOVERNMENT COUNSEL, LLC	401105070	APOTEX CORPORATION	2025	third_quarter	MAN	Federal policy relating to trade tariffs, strengthening domestic generic production and market access barriers for generic pharmaceuticals.	HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2025-10-02T21:18:44-04:00